Bill

Bill > H0109


FL H0109

FL H0109
Prescription Insulin Drugs


summary

Introduced
09/03/2019
In Committee
09/23/2019
Crossed Over
Passed
Dead
03/14/2020

Introduced Session

2020 Regular Session

Bill Summary

An act relating to prescription insulin drugs; creating ss. 627.64085 and 627.65746, F.S.; defining the term "prescription insulin drug"; requiring individual and group health insurance policies, respectively, to cap an insured's monthly cost-sharing obligation for covered prescription insulin drugs at a specified amount; providing construction; authorizing the Financial Services Commission to adopt rules; amending s. 641.31, F.S.; defining the term "prescription insulin drug"; requiring health maintenance contracts to cap a subscriber's monthly cost-sharing obligation for covered prescription insulin drugs at a specified amount; providing construction; authorizing the commission to adopt rules; providing an effective date.

AI Summary

This bill requires individual and group health insurance policies, as well as health maintenance contracts, to cap the monthly cost-sharing obligation for covered prescription insulin drugs at $100 per 30-day supply, regardless of the amount or type of insulin needed. The bill defines "prescription insulin drug" as a prescription drug containing insulin that is used to treat diabetes and has been prescribed as medically necessary by the treating physician. The bill also authorizes the Financial Services Commission to adopt rules to administer these new cost-sharing limits.

Committee Categories

Health and Social Services

Sponsors (12)

Last Action

Died in Health Market Reform Subcommittee (on 03/14/2020)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...